CD86 and neoplasm: Although TNF-α production by intratumoral dendritic cells showed no major differences (Figure 8F), rBCG-treated mice exhibited significantly elevated CD86 expression in tumor-associated macrophages (Figure 8H), suggesting improved costimulatory capacity within the tumor niche.